<p>C57BL/6 mice were vaccinated with untreated B16F10 cells ; mIFN-γ (50 IU/mL); GGTI-298 (10 µM); or mIFN-γ (50 IU/mL) and GGTI-298 (10 µM) pretreated B16F10 cells. (<b>A</b>) One month after vaccination tumor growth was measured after s.c. injection of 1×10<sup>5</sup> live B16F10 cells, by Vernier caliper every 3 days. Groups of 6 or 7 C57Bl/6 mice were tested. Data are representative of three independent experiments. (<b>B</b>) The number of tumor free mice were calculated for each kind of vaccination. Results are pooled for the three independent experiments.</p
ABSTRACT-BALB/c and DBAf mice were vaccinated with dif· ferent doses of a protein fraction of the mu...
<p>Mice were injected with 1×10<sup>5</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA...
Two approaches to immunological intervention in tumor–host interactions in mouse models are discusse...
<p>Four groups of C57Bl/6 mice were vaccinated with untreated B16F10 cells (NT); mIFN-γ (50 IU/mL) (...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p>(A) Correlation of the frequency of IFN-γ-producing cells and tumor development. Tumor inoculatio...
TS/A cells (a Balb/c-derived tumor cell line), when injected into syngenic mice, give rise to rapidl...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
(A) Representative diagram of vaccination strategy for therapeutic model. (B) Growth curve of B16-F1...
<p>C57BL/6J (WT) and FtDKO mice were vaccinated intravenously with LM-OVA and challenged with B16-OV...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>C57BL/6 mice were injected subQ with 5 x 10<sup>5</sup> E.G7 tumor cells. Mice were vaccinated wi...
ABSTRACT-BALB/c and DBAf mice were vaccinated with dif· ferent doses of a protein fraction of the mu...
<p>Mice were injected with 1×10<sup>5</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA...
Two approaches to immunological intervention in tumor–host interactions in mouse models are discusse...
<p>Four groups of C57Bl/6 mice were vaccinated with untreated B16F10 cells (NT); mIFN-γ (50 IU/mL) (...
<p>(A, B) The preventive effect of B16-mBD2 vaccination on the development of tumors. Groups of C57B...
<p>C57BL/6 mice were immunized with PBS, OVA, fucoidan or OVA + fucoidan on days 0, 15 and 30. On da...
<p>(A) Correlation of the frequency of IFN-γ-producing cells and tumor development. Tumor inoculatio...
TS/A cells (a Balb/c-derived tumor cell line), when injected into syngenic mice, give rise to rapidl...
<p>Mice were injected s.c. with B16 cells on day 0. Mice were immunized s.c. with 1x10<sup>6</sup> D...
(A) Representative diagram of vaccination strategy for therapeutic model. (B) Growth curve of B16-F1...
<p>C57BL/6J (WT) and FtDKO mice were vaccinated intravenously with LM-OVA and challenged with B16-OV...
<p>Mice (n = 5) were immunized with various DNA vaccines (mp53, CD40L, or mp53/CD40L) three times at...
<p>The time of morbidity was recorded for mice (each group, n = 10) inoculated with live tumor cells...
<p><b>A</b> Schematic illustration of the experimental set up. <b>B</b> Groups (n = 8) of C57BL/6 fe...
<p>C57BL/6 mice were injected subQ with 5 x 10<sup>5</sup> E.G7 tumor cells. Mice were vaccinated wi...
ABSTRACT-BALB/c and DBAf mice were vaccinated with dif· ferent doses of a protein fraction of the mu...
<p>Mice were injected with 1×10<sup>5</sup> live MCA-205, MCA-205-OVA, MCA-205-E1A-Δp300-OVA, or MCA...
Two approaches to immunological intervention in tumor–host interactions in mouse models are discusse...